In their study, the prognostic significance of Peli1 for OS was independent of international index (IPI) in all DLBCL patients (p=0.010 for Peli1; p<0.001 for IPI), but not in R-CHOP-treated patients in multivariate analysis for OS (p=0.073 for Peli1; p=0.015 for IPI). Here, PELI1 is linked to diffuse large B-cell lymphoma.